MDLZ vs ORMP
Mondelez International Inc (MDLZ) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
MDLZ currently screens at market cap $78.12B and trailing P/E 30.1. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the MDLZ and ORMP stock pages for the full models.
Not investment advice.